Pain management strategies for acute abdominal pain in the emergency department: a study from the Al-Hilla Teaching Hospital (Iraq)

Authors

  • Ali Jalil Al-Saigh
  • Noor Abdalwahd
  • Rusul W. Kadhum
  • Rafal J. Al-Saigh
  • Sally H. Al-Humadi
  • Noor Jalil Alsaigh

DOI:

https://doi.org/10.60988/p.v37i2S.167

Keywords:

acute abdominal pain; emergency department; pain management; analgesics; multimodal approac

Abstract

Acute abdominal pain is a frequent cause of emergency department (ED) visits, yet the management of pain in patients with acute abdominal pain remains controversial. Concerns about masking symptoms and delaying diagnosis have traditionally led to the withholding of analgesics prior to diagnosis. However, recent evidence suggests that early pain management does not compromise diagnostic accuracy or outcomes. This study evaluates the demographic and clinical characteristics of 97 patients presenting with acute abdominal pain at the Al-Hilla Teaching Hospital in Babylon, Iraq, from June 2023 to September 2023. The study focuses on their medication intake and pain management strategies, highlighting the effectiveness of a multimodal approach, including the use of esomeprazole, ketorolac, hyoscine butylbromide, ondansetron, and budesonide, in alleviating pain and associated symptoms. The results show that majority of the patients (90.7%) presented to the ED within 6 h of pain onset. The most frequently administered medications were esomeprazole (95.8%), ketorolac (70.1%), and antibiotics (64.9%). Pain subsided within 30–49 min in 60.8% of patients, demonstrating the effectiveness of early analgesia. The study supports the safe and timely administration of analgesics in the ED, challenging traditional practices and emphasizing the need for updated guidelines in order to improve patient care in emergency settings.

Author Biographies

Ali Jalil Al-Saigh

Al-Hilla Teaching Hospital, Babel Health Office, Hillah, Iraq

Noor Abdalwahd

Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Hillah, Iraq

Rusul W. Kadhum

Department of Pharmaceutics, College of Pharmacy, University of Babylon, Hillah, Iraq

Rafal J. Al-Saigh

Department of Clinical Laboratory Sciences, College of Pharmacy, University of Babylon, Hillah, Iraq

Sally H. Al-Humadi

College of Medicine, University of Babylon, Hillah, Iraq

Noor Jalil Alsaigh

Kerbala Health Office, Kerbala, Iraq

References

1. Ayoade B.A., Tade A.O., Salami B.A., Oladapo O. Administration of analgesics in patients with acute abdominal pain: a survey of the practice of doctors in a developing country. Int. J. Emerg. Med. 2(4), 211–215, 2009. DOI: 10.1007/s12245-009-0118-7

2. Brewster G.S., Herbert M.E., Hoffman J.R. Medical myth: analgesia should not be given to patients with an acute abdomen because it obscures the diagnosis. West. J. Med. 172(3), 209–210, 2000. DOI: 10.1136/ewjm.172.3.209

3. Mohammed I.A., Shakir H.F., Al-Kawaz H.S. Acute abdomen in patients above 60 years. Iraqi J. Community Med. 33(2), 51–56, 2020.

4. Hawkey C.J., Talley N.J., Scheiman J.M., Jones R.H., Långström G., Naesdal J., et al. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res. Ther. 9(1), R17, 2007. DOI: 10.1186/ar2124

5. Hutka B., Lázár B., Tóth A.S., Ágg B., László S.B., Makra N., et al. The nonsteroidal anti-inflammatory drug ketorolac alters the small intestinal microbiota and bile acids without inducing intestinal damage or delaying peristalsis in the rat. Front. Pharmacol. 12, 664177, 2021. DOI: 10.3389/fphar.2021.664177

6. Zhang L., Song J., Bai T., Lu X., Yang G., Qian W., et al. Effects of Buscopan on human gastrointestinal smooth muscle activity in an ex vivo model: are there any differences for various sections? Eur. J. Pharmacol. 780, 180–187, 2016. DOI: 10.1016/j.ejphar.2016.03.047

7. Cheng A. Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Paediatr. Child Health 16(3), 177–182, 2011. DOI: 10.1093/pch/16.3.177

8. López-Sanromán A., Clofent J., Garcia-Planella E., Menchén L., Nos P., Rodríguez-Lago I., et al. Reviewing the therapeutic role of budesonide in Crohn’s disease. Gastroenterol. Hepatol. 41(7), 458–471, 2018. DOI: 10.1016/j.gastrohep.2018.05.013

9. Bijur P.E., Mills A.M., Chang A.K., White D., Restivo A., Persaud S., et al. Comparative effectiveness of patient-controlled analgesia for treating acute pain in the emergency department. Ann. Emerg. Med. 70(6), 809–818, e2, 2017. DOI: 10.1016/j.annemergmed.2017.03.064

10. Hyland S.J., Brockhaus K.K., Vincent W.R., Spence N.Z., Lucki M.M., Howkins M.J., et al. Perioperative pain management and opioid stewardship: a practical guide. Healthcare (Basel) 9(3), 333, 2021. DOI: 10.3390/healthcare9030333

Downloads

Published

10-10-2025

How to Cite

[1]
Al-Saigh, A.J. et al. 2025. Pain management strategies for acute abdominal pain in the emergency department: a study from the Al-Hilla Teaching Hospital (Iraq). Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.167.